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Background
Cardiovascular diseases are the second leading non-AIDS
dependent cause of mortality for human immunodefi-
ciency virus-infected (HIV) patients. Thus, the evaluation
of cardiovascular risk factors (CVRF) and the identification
of persons at risk are necessary for the implementation of
prevention methods.
Methods
A retrospective cross-sectional study was performed on a
group of 50 HIV patients at the I Clinic of Infectious
Diseases Tg Mureş (33 male, average age: 27.1±7; average
duration of antiretroviral treatment: 11.16±6.88 years;
average TCD4+ lymphocyte (LTCD4+) count on last eva-
luation: 593.98±392.55 cells/µL; 38 in AIDS stage). From
the moment of diagnosis until July 2014, several classic
CVRF have been studied: age, sex, smoking, obesity, dysli-
pidemia, diabetes, hypertension and global cardiovascular
risk (CVR) estimated with Framingham score. The results
were correlated with: antiretroviral treatment (ART), the
number of ART combinations, LTCD4+ and hepatitis
B (HBV) coinfection. For statistical analysis the Student
and Mann-Whitney tests were used with 95% confidence
interval and statistical significance p<0.05.
Results
CVRF: hypertriglyceridemia, 29 patients (22 in stage C),
decreased high-density lipoproteins (HDL) 23 (elevated,
10), hypercholesterolemia 12, elevated low-density lipo-
protein (LDL) 7, smoking habit 16, obese 3, overweight
5, underweight 8, hypertension 2, diabetes 1. The Fra-
mingham test global scores: 6 moderate, 1 elevated, 43
decreased. A significant statistical difference can be
observed between the initial and final values of: total
cholesterol (TC), LDL and triglycerides (TG) p = 0.0002,
p = 0.0495, p = 0.0002. Patients with ≥3 combinations of
ART had a significantly larger average value of TC, LDL
and TG (p = 0.030, p = 0.041, p = 0.027) compared to
those with 1 combination.
Significant statistical differences are registered between:
average TC and TG values (p=0.0001 p = 0.0013) depend-
ing on the treatment with or without protease inhibitors
(PI); between HDL values for patients with LTCD4+ ≥500
cells/µL and those with TCD4+ <500 cells/µL (p=0.028).
Average TG values were significantly higher for HBV coin-
fections (p = 0.0349).
Conclusion
The most frequent CVRF were: hypertriglyceridemia
(58%), fall of HDL levels (46%), smoking (32%), hyperch-
olesterolemia (24%), decreased LDL levels (14%). The
lipid levels are influenced by: type of ART, number of
combinations, presence of HBV and the advanced stage
of disease. High levels of LTCD4+ and HDL can be con-
sidered protective factors. Because of the existence of
these risks, the initiation of a program for the reduction
of cardiovascular risks is necessary.
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